Medical Pharmacology Chapter 26: Renal Pharmacology
|
|
Background
Body fluid and electrolyte composition are regulated by the kidney
Drugs that interfere with renal transport may be useful in management of clinical disorders.
Diuretics are drugs which block renal ionic transport, causing diuresis {an increase in urine volume}, often associated with natriuresis (increase in sodium excretion)
Diuretics often act at different sites of the tubule transport system, at specific membrane transport proteins
Diuretics that act on specific membrane transport proteins include:
Loop diuretics
Thiazides
Amiloride (Midamor)
Triamterene (Dyrenium)
Diuretics may act through:
Osmotic effects (preventing water reabsorption) such as mannitol
Enzyme inhibition (carbonic anhydrase inhibitor) such as acetazolamide
Interaction with hormonal receptors, for example, spironolactone
Renal physiology and sites of diuretic action
|
|
|
|
Many solutes are reabsorbed in the early portions of the proximal tubule:
85% of filtered sodium bicarbonate
40% of sodium chloride
60% of water and
Nearly all of filtered organic solutes, including glucose and amino acids.
Glucose, amino acids, and other organic solutes are reabsorbed by specific transport systems
Sodium Bicarbonate and the Proximal Tubule
Mechanism of Action: In the proximal tubule, sodium bicarbonate reabsorption can be influenced by carbonic anhydrase inhibitors.
Sodium bicarbonate reabsorbed in the proximal tubule depends on the action of sodium/hydrogen exchanger which is found in the luminal membrane of the proximal tubule epithelial cell.
proton secreted into lumen (urine) combine with bicarbonate to form carbonic acid (H2CO3)
Carbonic acid is dehydrated by an enzyme carbonic anhydrase which is localized (among other places) on the brush border membrane.
The dehydration products carbon dioxide and water easily move across membranes. Carbon dioxide enters the proximal tubule by diffusion where it is rehydrated back to carbonic acid.
Carbonic acid dissociates back to bicarbonate and the proton (step one)
This cycle depends on carbonic anhydrase
Mechanism of Action: Inhibition of carbonic anhydrase decreases bicarbonate reabsorption in proximal tubule, which in turn decreases water reabsorption
Carbonic anhydrase inhibitor: acetazolamide (Diamox)
In the proximal tubule, water is reabsorbed in direct proportion to salt.
With a large concentration of impermeant solute, such as glucose or the diuretic mannitol, water reabsorption would decrease for osmotic reasons. (Mechanism for osmotic diuresis)
Located in the middle third proximal tubule
Organic acid secretory system secretes for example:
Uric acid
Antibiotics
Para-aminohippuric acid
Localized in both early and middle segments of the proximal tubule
Organic base secretory system secretes, for example:
Creatinine
Procainamide {antiarrhythmic drug}
Choline
Organic acid and base transport systems are important in delivery of diuretics to their site of action: luminal side
Drug interaction: diuretics and probenecid (secretory system inhibitor)
Water reabsorption
Driving force is osmotic, due to the hypertonic medullary fluid.
No active salt reabsorption, but impermeant solutes (mannitol, glucose) will inhibit water reabsorption.
This is a site of action for osmotic diuretics.
Thick ascending limb of the loop of Henle: active sodium chloride reabsorption, about 35% of filtered load.
Impermeable to water
Since reabsorption of sodium chloride at this site dilutes the fluid in the tubule, this segment may be referred to as "diluting segment."
Reabsorption of sodium chloride in the thick ascending limb is dependent upon the Na/K/2Cl co-transporter.
Loop diuretics block this transporter.
Examples of loop diuretics include:
Furosemide (Lasix)
Bumetanide (Bumex)
Ethacrynic acid (Edecrin)
Torsemide (Demadex)
Normal activity of this transporter and Na+/K+ ATPase results in an increase in intracellular potassium, potassium efflux, and a lumen-positive electrical potential:
This lumen-positive membrane potential provides the driving force for reabsorption of magnesium and calcium cations.
Therefore loop diuretics which inhibit the action of the sodium potassium chloride co-transporter, leading to increase sodium excretion also leads to increased magnesium and calcium loss.
Properties:
Impermeable to water
Sodium reabsorption (about 10% of filtered load) by sodium and chloride co-transporter
Further dilution of tubular fluids
Pharmacological blockade of sodium and chloride co-transporter:
Thiazide diuretics
No potassium recycling; no lumen-positive membrane potential; -- no calcium or magnesium loss by electrical forces
Calcium is actively reabsorbed by:
aAn apical calcium channel and
Na+/Ca2+ exchanger and
Is regulated by parathyroid hormone
Properties:
About 2% to 5% of sodium chloride reabsorption
Final site for sodium chloride reabsorption -- responsible for final sodium concentration in the urine
This site and late distal tubule represent the location where mineralocorticoids exert their effect
Major site of potassium secretion
Major site for sodium, potassium, and water transport
Major site for proton secretion is the intercalated cells
Separate sodium and potassium channels:
Significant driving force for sodium entry
Na+ after entering the principal cell is transported to the blood using the Na+/K+ ATPase driven transporter, with potassium translocated to the lumen urine.
The lumen-negative electrical potential drives chloride back to the blood.
Accordingly, delivery of increased sodium to the collecting tubule drives increased potassium efflux.
Diuretics (acting upstream) that increased delivery of sodium to the collecting tubule will cause potassium loss.
Delivery of bicarbonate which is not readily reabsorbed compared to chloride and thus increases lumen-negative potentials, will increase further potassium loss.
Diuretic-induced potassium loss, which is clinically important, results from the above mechanisms coupled with enhanced aldosterone secretion due to volume depletion.
Jackson, E.K. Diuretics In, Goodman and Gillman's The Pharmacological Basis of Therapeutics, (Hardman, J.G, Limbird, L.E, Molinoff, P.B., Ruddon, R.W, and Gilman, A.G.,eds) The McGraw-Hill Companies, Inc.,1996, pp. 685- 713
Jackson, E.K. Vasopressin and Other Agents Affecting the Renal Conservation of Water In, Goodman and Gillman's The Pharmacological Basis of Therapeutics, (Hardman, J.G, Limbird, L.E, Molinoff, P.B., Ruddon, R.W, and Gilman, A.G.,eds) The McGraw-Hill Companies, Inc.,1996, pp.715-732
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |